Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).

International audience

Data and Resources

Additional Info

Field Value
Source ISSN: 0008-543X
Author Morschhauser, Franck, Mounier, Nicolas, Sebban, Catherine, Brice, Pauline, Solal-Celigny, Phillippe, Tilly, Herve, Feugier, Pierre, Fermé, Christophe, Copin, Marie Christine, Lamy, Thierry
Maintainer CCSD
Last Updated October 30, 2026, 15:19 (UTC)
Created October 30, 2026, 15:19 (UTC)
Identifier hal-00744246
Language en
contributor Service d'onco-hématologie ; Centre Hospitalier Universitaire de Nice (CHU Nice)-Hôpital l'Archet [Nice] (CHU Nice)
creator Morschhauser, Franck
date 2010-09-15T00:00:00
harvest_object_id 4da1bc45-6c8c-4236-9ed3-c30fe9b0a543
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-10-09T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.1002/cncr.25280
set_spec type:ART